FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmaceutical industry, namely to composition for transcutaneous delivery of medication, which is realised from mixture, which contains: therapeutically efficient amount of medication, including initial medication and promedicine, as well as pharmaceutically acceptable carrier, both initial medication and promedicine being present in amount sufficient for manifestation of pharmacologic activity.
EFFECT: in preferable version of invention implementation mixture includes therapeutically efficient amount of pharmaceutically active agent, which contains ACE inhibitor, such as ramipril, promedicine being promedicine of ACE inhibitor, such as ethyl ester of ramipril and/or methyl ester of ramipril.
5 cl, 10 ex, 9 dwg
